SEC Comment Letter for DermTech, Inc. (DMTKQ) (CIK 0001651944) — Apr 29, 2020
DermTech, Inc. (DMTKQ) (CIK 0001651944)
Date: April 29, 2020 · CIK: 0001651944 · Accession: 0000000000-20-003680
AI Filing Summary & Sentiment
File numbers found in text: 333-38118
Letter
United States securities and exchange commission logo April 29, 2020 Kevin Sun Chief Financial Officer, Treasurer and Secretary DermTech, Inc. 11099 N. Torrey Pines Road, Suite 100 La Jolla, CA 92037 Re:DermTech, Inc. Preliminary Proxy Statement on Schedule 14A Filed April 16, 2020 File No. 333-38118 Dear Mr. Sun: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences
Show Raw Text
United States securities and exchange commission logo
April 29, 2020
Kevin Sun
Chief Financial Officer, Treasurer and Secretary
DermTech, Inc.
11099 N. Torrey Pines Road, Suite 100
La Jolla, CA 92037
Re:DermTech, Inc.
Preliminary Proxy Statement on Schedule 14A
Filed April 16, 2020
File No. 333-38118
Dear Mr. Sun:
We have completed our review of your filing. We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences